Gene · 7468
Papers2,351
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,351
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Comparing self-reported race and genetic ancestry for identifying potential differentially methylated sites in endometrial cancer: insights from African ancestry proportions using machine learning models. | Mol Oncol | 2025 | 40045917 | PubTator, text mining | PubMed |
| Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma. | Blood | 2025 | 40009503 | PubTator, text mining | PubMed |
| Single-cell DNA and surface protein characterization of high hyperdiploid acute lymphoblastic leukemia at diagnosis and during treatment. | Hemasphere | 2025 | 39944233 | PubTator, text mining | PubMed |
| SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation. | Genome Biol | 2025 | 39910618 | PubTator, text mining | PubMed |
| NSD2 mediated H3K36me2 promotes pulmonary arterial hypertension by recruiting FOLR1 and metabolism reprogramming. | Cell Signal | 2025 | 39798773 | PubTator, text mining | PubMed |
| High-risk MCL: recognition and treatment. | Blood | 2025 | 39786418 | PubTator, text mining | PubMed |
| Facile preparation of sulfonium peptide and protein probes for selective crosslinking of methyllysine readers. | Chem Sci | 2025 | 39720136 | PubTator, text mining | PubMed |
| Discovery of SET domain-binding primary alkylamine-tethered degraders for the simultaneous degradation of NSD2-long and RE-IIBP isoforms. | Eur J Med Chem | 2025 | 39705735 | PubTator, text mining | PubMed |
| Covalent Proximity Inducers. | Chem Rev | 2025 | 39692621 | PubTator, text mining | PubMed |
| Downregulation of the splicing regulator NSRP1 confers resistance to CDK4/6 inhibitors via activation of interferon signaling in breast cancer. | J Biol Chem | 2025 | 39667501 | PubTator, text mining | PubMed |
| The C-terminal PHDVC5HCH tandem domain of NSD2 is a combinatorial reader of unmodified H3K4 and tri-methylated H3K27 that regulates transcription of cell adhesion genes in multiple myeloma. | Nucleic Acids Res | 2025 | 39656918 | PubTator, text mining | PubMed |
| Identification of potential methyltransferase NSD2 enzymatic inhibitors through a multi-step structure-based drug design. | Mol Divers | 2025 | 39644397 | PubTator, text mining | PubMed |
| Genetic Findings in Short Turkish Children Born to Consanguineous Parents. | Horm Res Paediatr | 2025 | 38838658 | PubTator, text mining | PubMed |
| Conditional knockout of the NSD2 gene in mouse intestinal epithelial cells inhibits colorectal cancer progression. | Animal Model Exp Med | 2025 | 38400589 | PubTator, text mining | PubMed |
| Novel integrated Omics based computational approach for drug repurposing for non-muscle invasive bladder cancer (NMIBC). | J Biomol Struct Dyn | 2025 | 38247255 | PubTator, text mining | PubMed |
| Loss of function in NSD2 causes DNA methylation signature similar to that in Wolf-Hirschhorn syndrome. | Genet Med Open | 2024 | 39669601 | PubTator, text mining | PubMed |
| Epithelial NSD2 maintains FMO-mediated taurine biosynthesis to prevent intestinal barrier disruption. | Clin Transl Med | 2024 | 39658533 | PubTator, text mining | PubMed |
| A familial chromosome 4p16.3 terminal microdeletion that does not cause Wolf-Hirschhorn (4p-) syndrome. | Chromosome Res | 2024 | 39509040 | PubTator, text mining | PubMed |
| Rational fragment-based design of compounds targeting the PWWP domain of the HRP family. | Eur J Med Chem | 2024 | 39461037 | PubTator, text mining | PubMed |
| Histone methyltransferase WHSC1 cooperate with YBX1 promote glioblastoma progression via regulating PLK1 expression. | Cell Signal | 2024 | 39406278 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7468/papers?page=6